Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Minerva Neurosciences (NERV) Invested Capital (2016 - 2026)

Minerva Neurosciences filings provide 3 years of Invested Capital readings, the most recent being $8.0 million for Q4 2021.

  • On a quarterly basis, Invested Capital fell 84.86% to $8.0 million in Q4 2021 year-over-year; TTM through Dec 2021 was $8.0 million, a 84.86% decrease, with the full-year FY2021 number at $8.0 million, down 84.86% from a year prior.
  • Invested Capital hit $8.0 million in Q4 2021 for Minerva Neurosciences, down from $28.1 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $58.0 million in Q3 2020 to a low of $8.0 million in Q4 2021.
  • Median Invested Capital over the past 3 years was $36.2 million (2021), compared with a mean of $36.8 million.
  • The widest YoY moves for Invested Capital: up 143.63% in 2021, down 84.86% in 2021.
  • Minerva Neurosciences' Invested Capital stood at $27.8 million in 2019, then soared by 89.57% to $52.7 million in 2020, then tumbled by 84.86% to $8.0 million in 2021.
  • The last three reported values for Invested Capital were $8.0 million (Q4 2021), $28.1 million (Q3 2021), and $36.2 million (Q2 2021) per Business Quant data.